Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry

Archives of Cardiovascular Diseases · Published 2026-06-01 · DOI 10.1016/j.acvd.2026.06.003

Free full text

Authors (25)

Manveer Singh, Etienne Puymirat, Christophe Robin, Thibault Perret, Franck Barbou, Erwan Bressollette, Youcef Afifi, Gauthier Mouillet, Sébastien Hess, François Tarragano, Akram Chmait, Nicolas Meneveau, Nizar Ben Mansour, Stéphane Rias, Tahar Lazizi, Stephan Chassaing, Guillaume Cayla, Philippe Commeau, Hakim Benamer, Michel Zeitouni, René Koning, Pascal Motreff, Eric Van Belle, Céline Lambert, Grégoire Rangé

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Singh, M., Puymirat, E., Robin, C., et al. (2026). Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2026.06.003

Related articles